Description
Introduction Of The Trastuzumab Ujvira 100mg Injection:
Ujvira 100mg Injection is a specialised injection used to treat certain types of breast and stomach cancers that produce too much of a protein called HER2. By targeting these specific cancer cells, it helps slow down or stop their growth. This medicine is a key part of targeted cancer therapy prescribed by oncology specialists.
Ujvira 100mg Injection is given as an injection or infusion, typically once every week or every three weeks, depending on your treatment plan. Consistency is vital, so keeping all your scheduled appointments is highly recommended. To support your body during treatment, maintaining a balanced diet, staying well-hydrated, and getting plenty of rest can help manage physical demands.
Some people experience mild side effects like chills, fever, or nausea, particularly during or after the first few sessions. However, you must seek immediate medical help if you experience serious symptoms such as shortness of breath, swelling in your legs, or a rapid heartbeat, as these can point to heart or lung complications.
Before starting Ujvira 100mg Injection, inform your doctor if you have a history of heart disease, high blood pressure, or lung disorders. Do not take this medicine if you have had a severe allergic reaction to it or its ingredients in the past. Pregnant women should also avoid this medicine as it can cause harm to an unborn baby.
Active Ingredient/Salt:
- Trastuzumab Emtansine
Uses of Ujvira 100mg Injection:
Ujvira 100mg Injection is used to treat certain types of breast and stomach cancers that produce too much HER2. The detailed uses of Ujvira 100 mg Injection are as follows:
- HER2-positive breast cancer: Ujvira 100 mg Injection helps by targeting and blocking the HER2 receptors on cancer cells, which slows down tumor growth and reduces the risk of the cancer returning after surgery or chemotherapy.
- HER2-positive metastatic stomach (gastric) cancer: Ujvira 100 mg Injection works in combination with chemotherapy to slow the progression of advanced stomach or gastroesophageal junction cancers that overexpress the HER2 protein.
Benefits of Ujvira 100mg Injection:
Ujvira 100mg Injection offers significant clinical benefits for individuals facing specific types of aggressive cancers. By focusing directly on cancer cells rather than all rapidly dividing cells, it helps limit damage to healthy tissues, resulting in a more targeted approach to cancer care. Key benefits include:
- Reduced risk of cancer recurrence: When used after surgery for early-stage breast cancer, it significantly lowers the chances of the cancer coming back.
- Extended survival times: In advanced or metastatic cases of breast and stomach cancer, it helps control tumour growth, which can help extend life and improve comfort.
- Synergy with chemotherapy: It enhances the effectiveness of standard chemotherapy drugs, making the overall treatment regimen more successful at shrinking tumours.
Mode Of Action For Trastuzumab Ujvira 100mg Injection:
Trastuzumab emtansine’s includes attaching to the HER2 protein on cancer cells’ surfaces, inhibiting its signalling pathways, and inducing the immune system to destroy the cancer cells. The chemotherapeutic drug DM1 is released from T-DM1 once it has entered the cell, killing the cancer cell.

Reviews
There are no reviews yet.